MeSH term
Frequency | Condition_Probility | Animals | 21 | 0.0 |
Aortic Aneurysm/surgery | 2 | 13.0 |
Bioprosthesis/standards | 2 | 15.0 |
Equipment Failure | 2 | 8.0 |
Heart Valve Diseases/pathology/surgery | 2 | 15.0 |
Heart Valve Prosthesis/*standards | 2 | 15.0 |
Humans | 36 | 0.0 |
Postoperative Complications/etiology | 2 | 5.0 |
Prosthesis Design | 2 | 4.0 |
*Stents | 2 | 3.0 |
Swine | 3 | 0.0 |
Cell Line | 8 | 0.0 |
Cell Line, Tumor | 4 | 0.0 |
Immunoblotting | 3 | 0.0 |
Kinetics | 6 | 0.0 |
Models, Biological | 2 | 0.0 |
Plasmids/metabolism | 2 | 0.0 |
*Promoter Regions (Genetics) | 2 | 0.0 |
Protein Binding | 3 | 0.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 22 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 11 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 9 | 0.0 |
Time Factors | 3 | 0.0 |
Trans-Activators/*metabolism | 4 | 0.0 |
*Transcription, Genetic | 2 | 0.0 |
Transfection | 10 | 0.0 |
Base Sequence | 7 | 0.0 |
*Gene Expression Regulation, Enzymologic | 2 | 0.0 |
Leucine Zippers | 6 | 3.0 |
Molecular Sequence Data | 10 | 0.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
RNA, Messenger/genetics | 4 | 0.0 |
Sequence Deletion | 2 | 0.0 |
Transcription Factors/*metabolism | 7 | 0.0 |
Tumor Cells, Cultured | 7 | 0.0 |
Cell Differentiation | 2 | 0.0 |
Cell Division | 2 | 0.0 |
Oligonucleotide Array Sequence Analysis | 7 | 0.0 |
Amino Acid Sequence | 8 | 0.0 |
Cells, Cultured | 6 | 0.0 |
*Gene Expression Regulation, Neoplastic | 3 | 0.0 |
Genes, Reporter | 4 | 0.0 |
Recombinant Proteins/chemistry/metabolism | 2 | 0.0 |
Sequence Alignment | 3 | 0.0 |
Sequence Homology, Amino Acid | 4 | 0.0 |
Transcription Factors/metabolism | 2 | 0.0 |
Antioxidants/metabolism | 2 | 2.0 |
DNA-Binding Proteins/*metabolism | 2 | 0.0 |
Antineoplastic Agents/*pharmacology | 2 | 0.0 |
Gene Expression Regulation, Neoplastic/drug effects | 2 | 0.0 |
Mice | 12 | 0.0 |
Mice, Nude | 2 | 0.0 |
Transplantation, Heterologous | 2 | 0.0 |
DNA-Binding Proteins/physiology | 2 | 0.0 |
Leucine Zippers/*physiology | 2 | 33.0 |
Gene Expression Profiling | 4 | 0.0 |
*Gene Expression Regulation | 3 | 0.0 |
Hela Cells | 4 | 0.0 |
Phosphorylation | 6 | 0.0 |
Polyribosomes/metabolism | 2 | 7.0 |
*Protein Biosynthesis | 3 | 0.0 |
Transcription Factors/genetics/*metabolism | 4 | 0.0 |
eIF-2 Kinase/genetics/metabolism | 3 | 60.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Transcription, Genetic/physiology | 2 | 1.0 |
Cloning, Molecular | 4 | 0.0 |
Conserved Sequence | 2 | 0.0 |
Female | 4 | 0.0 |
Rats | 3 | 0.0 |
Precipitin Tests | 3 | 0.0 |
Transcription, Genetic | 3 | 0.0 |
Male | 2 | 0.0 |
Middle Aged | 2 | 0.0 |
CHO Cells | 2 | 0.0 |
Hamsters | 3 | 0.0 |
Subcellular Fractions/metabolism | 2 | 0.0 |
DNA-Binding Protein, Cyclic AMP-Responsive/*metabolism | 2 | 2.0 |
Neurons/metabolism | 2 | 0.0 |
Transcription Factors/*genetics/*metabolism | 2 | 1.0 |
Gene Library | 3 | 0.0 |
Immunohistochemistry | 2 | 0.0 |
Pituitary Gland, Anterior/*metabolism | 2 | 14.0 |
Two-Hybrid System Techniques | 2 | 0.0 |
3T3 Cells | 2 | 0.0 |
Binding Sites | 3 | 0.0 |
Cell Nucleus/metabolism | 2 | 0.0 |
Transcription Factors/genetics/metabolism | 2 | 0.0 |
DNA, Complementary/metabolism | 3 | 0.0 |
DNA Primers | 4 | 0.0 |
Up-Regulation | 2 | 0.0 |
Up-Regulation/drug effects | 2 | 0.0 |
Trans-Activation (Genetics) | 2 | 0.0 |
Protein Folding | 2 | 0.0 |
